Carregant...
Thalidomide maintenance following high-dose melphalan with autologous stem cell support in myeloma
BACKGROUND: Recent experience with thalidomide maintenance after high-dose chemotherapy with autologous stem cell support has demonstrated improvement in progression-free and overall survival. We further explored the tolerability and efficacy of lower doses of maintenance thalidomide in this single...
Guardat en:
| Autors principals: | , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2008
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2913594/ https://ncbi.nlm.nih.gov/pubmed/18650178 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3816/CLM.2008.n.018 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|